Jump to content


This topic is now archived and is closed to further replies.


Mylan buys Merck generic drug unit for $6.6 billion

Recommended Posts

The Canonsburg-based company announced late Saturday that it was buying the generics arm of Germany-based Merck KGaA for $6.6 billion, a blockbuster deal that will triple Mylan's size and make it a major player overseas.

Share this post

Link to post
Share on other sites

  • Recently Browsing   0 members

    No registered users viewing this page.

  • Create New...

Important Information

By using this site you agree to our Terms of Use and Privacy Policy. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.